§ 4772. Opioid Settlement Advisory Committee
(a) Creation. There is created the Opioid Settlement Advisory Committee to provide advice and recommendations
regarding remediation spending from the Opioid Abatement Special Fund established
pursuant to this subchapter.
(b) Membership.
(1) The Advisory Committee shall be composed of the following members and shall reflect
the diversity of Vermont in terms of gender, race, age, ethnicity, sexual orientation,
gender identity, disability status, and socioeconomic status and ensure inclusion
of individuals with lived experience of opioid use disorder and their family members
whenever possible:
(A) the Commissioner of Health or designee, who shall serve as a nonvoting chair;
(B) the Chief Prevention Officer established pursuant to 3 V.S.A. § 2321;
(C) one current member of the House of Representatives, appointed by the Speaker of the
House;
(D) one current member of the Senate, appointed by the Committee on Committees;
(E) a primary care prescriber with experience providing medication for opioid use disorder
within the Blueprint for Health hub and spoke model, appointed by the Executive Director
of the Blueprint for Health, to provide a statewide perspective on the provision of
medication for opioid use disorder services;
(F) a provider with academic research credentials, appointed by the University of Vermont,
to provide a statewide perspective on academic research relating to opioid use disorder;
(G) two individuals with lived experience of opioid use disorder, including at least one
of whom is in recovery, one member appointed by the Howard Center’s Safe Recovery
program and one member appointed by the Vermont Association of Mental Health and Addiction
Recovery, to provide a statewide perspective on the experience of living with opioid
use disorder;
(H) an assistant judge, appointed by the Vermont Association of County Judges; and
(I) seven individuals, each employed by or an agent of a different city or town that collectively
reflect Vermont’s diverse population and geography, appointed by the Vermont League
of Cities and Towns.
(2)(A) The term of office of each appointed member shall be four years. Of the members first
appointed, eight shall be appointed for a term of three years and eight shall be appointed
for a term of four years. Members shall hold office for the term of their appointments
and until their successors have been appointed. All vacancies shall be filled for
the balance of the unexpired term in the same manner as the original appointment.
Members are eligible for reappointment.
(B) A member may be removed from the Advisory Committee by the member’s appointing entity
for cause, which includes only neglect of duty, gross misconduct, conviction of a
crime, or inability to perform the responsibilities of the office. The Chair of the
Advisory Committee shall simultaneously notify the Governor, the Speaker of the House,
and the President Pro Tempore that the member has been removed from the Advisory Committee.
(c) Powers and duties. The Advisory Committee shall demonstrate broad ongoing consultation with individuals
living with opioid use disorder about their direct experience with related systems,
including medication for opioid use disorder, residential treatment, recovery services,
harm reduction services, overdose, supervision by the Department of Corrections, and
involvement with the Department for Children and Families’ Family Services Division.
To that end, the Advisory Committee shall demonstrate consultation with individuals
with direct lived experience of opioid use disorder, frontline support professionals,
the Substance Misuse Oversight Prevention and Advisory Council, and other stakeholders
to identify spending priorities as related to opioid use disorder prevention, intervention,
treatment, and recovery services and harm reduction strategies for the purpose of
providing recommendations to the Governor, the Department of Health, and the General
Assembly on prioritizing spending from the Opioid Abatement Special Fund. The Advisory
Committee shall consider:
(1) the impact of the opioid crisis on communities throughout Vermont, including communities’
abatement needs and proposals for abatement strategies and responses;
(2) the perspectives of and proposals from opioid use disorder prevention coalitions,
recovery centers, and medication for opioid use disorder providers; and
(3) the ongoing challenges of the opioid crisis on marginalized populations, including
individuals who have a lived experience of opioid use disorder.
(d) Assistance. The Advisory Committee shall have the administrative, technical, and legal assistance
of the Department of Health.
(e) Presentation. Annually, the Advisory Committee shall vote on its recommendations. Recommendations
shall be informed by outcomes and measurements reported by previous grantees. If the
recommendations are supported by an affirmative vote of the majority, the Advisory
Committee shall present its recommendations for expenditures from the Opioid Abatement
Special Fund established pursuant to this subchapter to the Department of Health and
concurrently submit its recommendations in writing to the House Committees on Appropriations
and on Human Services and the Senate Committees on Appropriations and on Health and
Welfare. The Advisory Committee’s written recommendations shall address how each recommendation
meets one or more of the criteria listed in subsections 4774(b) and (c) of this subchapter.
The Advisory Committee shall give priority consideration to services requiring funding
on an ongoing basis.
(f) Meetings.
(1) The Commissioner of Health shall call the first meeting of the Advisory Committee
to occur on or before June 30, 2022.
(2) Annually, the Advisory Committee shall elect a voting vice chair from among its nongovernmental
members.
(3) The Advisory Committee shall meet at least quarterly but not more than 12 times per
calendar year.
(4) The Advisory Committee shall adopt procedures to govern its proceedings and organization,
including voting procedures and how the staggered terms shall be apportioned among
members.
(5) All meetings of the Advisory Committee shall be consistent with Vermont’s Open Meeting
Law pursuant to 1 V.S.A. chapter 5, subchapter 2.
(g) Compensation and reimbursement.
(1) For attendance at meetings during adjournment of the General Assembly, a legislative
member of the Advisory Committee serving in the member’s capacity as a legislator
shall be entitled to per diem compensation and reimbursement of expenses pursuant
to 2 V.S.A. § 23 for not more than 12 meetings per year. These payments shall be appropriated from
the Opioid Abatement Special Fund.
(2) Other members of the Advisory Committee shall be entitled to per diem compensation
and reimbursement of expenses as permitted under 32 V.S.A. § 1010 for not more than 12 meetings per year. These payments shall be appropriated from
the Opioid Abatement Special Fund. (Added 2021, No. 118 (Adj. Sess.), § 1, eff. May 16, 2022; amended 2023, No. 87 (Adj. Sess.), § 82, eff. March 13, 2024; 2023, No. 113 (Adj. Sess.), § E.312.1, eff. July 1, 2024; 2025, No. 16, § 2, eff. July 1, 2025.)